The effect of splenopentin (DA SP-5) on In vitro myelopoiesis and on azt-induced bone marrow toxicity
- 30 April 1993
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 15 (3) , 269-273
- https://doi.org/10.1016/0192-0561(93)90035-w
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cytofluorometric and cytomorphologic analysis of human bone marrow cells derived fromstromal cultures stimulated by granulocyte‐macrophage colony‐stimulating factor, interferon‐γ and splenopentin pentapeptideEuropean Journal of Immunology, 1990
- Splenopentin (DAc-SP-5) accelerates the restoration of myelopoietic and immune systems after sublethal radiation in miceInternational Journal of Immunopharmacology, 1990
- Stimulation of the recruitment of epidermal Langerhans cells by splenopentinArchives of Dermatological Research, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Effect of Splenopentin (SP-5) on the Antibody Formation in Immunosuppressed MiceExperimental and Clinical Endocrinology & Diabetes, 1986
- Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factorsDifferentiation, 1986
- Molecular Cloning of a Complementary DNA Encoding Human Macrophage-Specific Colony-Stimulating Factor (CSF-1)Science, 1985
- The Granulocyte-Macrophage Colony-Stimulating FactorsScience, 1985
- Epidermal Langerhans cells are derived from cells originating in bone marrowNature, 1979